Peter Ambrose Lander

Person

Indianapolis, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds and methods for modulating FXR
- Patent number 8,106,077
- Issue date Jan 31, 2012
- Eli Lilly and Company
- Michael Gregory Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods for modulating FX-receptors
- Patent number 7,863,302
- Issue date Jan 4, 2011
- Eli Lilly and Company
- Michael Gregory Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FXR agonists
- Patent number 7,846,960
- Issue date Dec 7, 2010
- Eli Lilly and Company
- Michael Gregory Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods for treating dyslipidemia
- Patent number 7,470,705
- Issue date Dec 30, 2008
- Eli Lilly and Company
- Michael Gregory Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dihydroindol-2-one derivatives as steroid hormone nuclear receptor...
- Patent number 7,250,442
- Issue date Jul 31, 2007
- Eli Lilly and Company
- Matthew Lee Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods for inhibiting MRP1
- Patent number 7,064,131
- Issue date Jun 20, 2006
- Eli Lilly and Company
- Peter Ambrose Lander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compounds for inhibiting MRP1
- Patent number 6,743,794
- Issue date Jun 1, 2004
- Eli Lilly and Company
- Rosanne Bonjouklian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic compounds as MRP1-inhibitors
- Patent number 6,673,809
- Issue date Jan 6, 2004
- Eli Lilly and Company
- Peter Ambrose Lander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and method for inhibiting MRP1
- Patent number 6,670,373
- Issue date Dec 30, 2003
- Eli Lilly and Company
- Rosanne Bonjouklian
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
FXR AGONISTS
- Publication number 20090270460
- Publication date Oct 29, 2009
- Michael Gregory Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING FXR
- Publication number 20090093524
- Publication date Apr 9, 2009
- Michael Gregory Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds and Methods for Modulating Fx-Receptors
- Publication number 20080306125
- Publication date Dec 11, 2008
- Michael Gregory Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds and methods for treating dyslipidemia
- Publication number 20070173526
- Publication date Jul 26, 2007
- Eli Lilly and Company
- Michael Gregory Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Indole-derivative modulators of steroid hormone nuclear receptors
- Publication number 20060235222
- Publication date Oct 19, 2006
- Eli Lilly and Company
- Michael Gregory Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Dihydroindol-2-one derivatives as steroid hormone nuclear receptor...
- Publication number 20050054712
- Publication date Mar 10, 2005
- Timothy Alan Grese
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds and methods for inhibiting mrp1
- Publication number 20040235880
- Publication date Nov 25, 2004
- Peter Ambrose Lander
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds and methods for inhibiting MRP1
- Publication number 20040077675
- Publication date Apr 22, 2004
- Rosanne Bonjouklian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tricyclic compounds as mrp1-inhibitors
- Publication number 20030216425
- Publication date Nov 20, 2003
- Peter Ambrose Lander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and compounds for inhibiting mrp1
- Publication number 20030100576
- Publication date May 29, 2003
- Rosanne Bonjouklian
- C07 - ORGANIC CHEMISTRY

Peter Ambrose Lander

Person

Patents Grantslast 30 patents

Compounds and methods for modulating FXR

Compounds and methods for modulating FX-receptors

FXR agonists

Compounds and methods for treating dyslipidemia

Dihydroindol-2-one derivatives as steroid hormone nuclear receptor...

Compounds and methods for inhibiting MRP1

Methods and compounds for inhibiting MRP1

Tricyclic compounds as MRP1-inhibitors

Compounds and method for inhibiting MRP1

Patents Applicationslast 30 patents

FXR AGONISTS

COMPOUNDS AND METHODS FOR MODULATING FXR

Compounds and Methods for Modulating Fx-Receptors

Compounds and methods for treating dyslipidemia

Indole-derivative modulators of steroid hormone nuclear receptors

Dihydroindol-2-one derivatives as steroid hormone nuclear receptor...

Compounds and methods for inhibiting mrp1

Compounds and methods for inhibiting MRP1

Tricyclic compounds as mrp1-inhibitors

Methods and compounds for inhibiting mrp1